Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Vaccine

• Publication date

  2005-05-31

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/J.VACCINE.2005.02.020PMID 15893618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental Infection of Cats and Dogs with West Nile Virus

  2004cited by this paper
• Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses.

  2004cited by this paper
• Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.

  2004cited by this paper
• B Cells and Antibody Play Critical Roles in the Immediate Defense of Disseminated Infection by West Nile Encephalitis Virus

  2003cited by this paper
• West Nile Virus Encephalitis and Myocarditis in Wolf and Dog

  2003cited by this paper
• Serological, Reverse Transcriptase–Polymerase Chain Reaction, and Immunohistochemical Detection of West Nile Virus in a Clinically Affected Dog

  2003cited by this paper
• Antibody Prophylaxis and Therapy against West NileVirus Infection in Wild-Type and ImmunodeficientMice

  2003cited by this paper
• CD8+ T Cells Mediate Recovery andImmunopathology in West Nile VirusEncephalitis

  2003cited by this paper
• IFN-γ-Producing γδ T Cells Help Control Murine West Nile Virus Infection 1

  2003cited by this paper
• IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection.

  2003cited by this paper
• Experimental Infection of Horses with West Nile virus

  2002cited by this paper
• Immunization of Mice Against West Nile Virus with Recombinant Envelope Protein1

  2001cited by this paper
• Exposure of domestic mammals to West Nile virus during an outbreak of human encephalitis, New York City, 1999.

  2001cited by this paper
• West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays

  2001cited by this paper
• West Nile viral encephalitis.

  2000cited by this paper
• The Anamnestic Neutralizing Antibody Response Is Critical for Protection of Mice from Challenge following Vaccination with a Plasmid Encoding the Japanese Encephalitis Virus Premembrane and Envelope Genes

  1999cited by this paper
• Safe and effective poxvirus vectors--NYVAC and ALVAC.

  1994cited by this paper
• Susceptibility of dogs to West Nile virus: a survey and pathogenicity trial.

  1989cited by this paper
• Studies on the occurrence and distribution of HI antibodies against some arboviruses in the serum of domestic mammals in Puglia.

  1977cited by this paper
• Response of Young Dogs to West Nile Virus

  1953cited by this paper

• West Nile Virus: Epidemiology, Surveillance, and Prophylaxis with a Comparative Insight from Italy and Iran

  2026cites this paper
• Novel approaches for the rapid development of rationally designed arbovirus vaccines

  2023cites this paper
• Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development

  2023cites this paper
• A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications

  2021cites this paper
• Virome Diversity among Mosquito Populations in a Sub-Urban Region of Marseille, France

  2021cites this paper
• West Nile Virus

  2021cites this paper
• West Nile Virus

  2020cites this paper
• West Nile Virus: An Update on Pathobiology, Epidemiology, Diagnostics, Control and “One Health” Implications

  2020cites this paper
• Protective Efficacy of a Chimeric Insect-Specific Flavivirus Vaccine against West Nile Virus

  2020cites this paper
• West Nile Virus: Veterinary Health and Vaccine Development

  2019cites this paper
• Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): avian mycoplasmosis (Mycoplasma gallisepticum, M. meleagridis)

  2017cites this paper
• Les caractéristiques environnementales du risque d’exposition aux arbovirus au Québec

  2017cites this paper
• Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): West Nile fever

  2017cites this paper
• Data collection for risk assessments on animal health (Acronym: DACRAH) : Final Report

  2017cites this paper
• A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations

  2016cites this paper
• Knowledge base for the assessment of environmental risks by the use of genetically modified virus-vectored vaccines for domesticated animals. Scientific Opinion of the Panel on Microbial Ecology of the Norwegian Scientific Committee for Food Safety

  2016cites this paper
• Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry

  2016cites this paper
• Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens.

  2016cites this paper
• West Nile virus infection in cats

  2015cites this paper
• The Evolution of Poxvirus Vaccines

  2015cites this paper
• ABCD guidelines on prevention and management

  2015cites this paper
• Pathogenesis of West Nile Virus in Humans

  2015cites this paper
• Current trends in West Nile virus vaccine development

  2014cites this paper
• Development of Sheep Pox Virus Vectored Foot and Mouth Disease Vaccine for Sheep

  2014cites this paper
• An Overview of Live Attenuated Recombinant Pseudorabies Viruses for Use as Novel Vaccines

  2014cites this paper
• Genetic Screen of a Mutant Poxvirus Library Identifies an Ankyrin Repeat Protein Involved in Blocking Induction of Avian Type I Interferon

  2013cites this paper
• Domestic goose as a model for West Nile virus vaccine efficacy.

  2013cites this paper
• Vaccines in Development against West Nile Virus

  2013influential citation
• A Review of Vaccine Approaches for West Nile Virus

  2013cites this paper
• Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection.

  2012cites this paper
• Immunization of West Nile recombinant envelope Domain III with equine CD40 ligand protein vaccine induced specific immune response in rabbits and horses

  2012cites this paper
• Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing ORF2/ORF1 of PCV2 and P1 2A of FMDV

  2012cites this paper
• Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.

  2011cites this paper
• Efficacy of Three Vaccines in Protecting Western Scrub-Jays (Aphelocoma californica) from Experimental Infection with West Nile Virus: Implications for Vaccination of Island Scrub-Jays (Aphelocoma insularis)

  2011cites this paper
• Serological evidence of West Nile virus in dogs and cats in China

  2011cites this paper
• Vaccine Development Against West Nile Virus

  2009influential citation
• Effects of the number of amino acid residues in the signal segment upstream or downstream of the NS2B-3 cleavage site on production and secretion of prM/M-E virus-like particles of West Nile virus.

  2009cites this paper
• Chapter 39 – West Nile

  2009cites this paper
• The molecular basis of antibody protection against West Nile virus.

  2008cites this paper
• Phylogenetics and New Approaches to Vaccine Development for West Nile

  2008cites this paper
• Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01

  2008cites this paper
• A global perspective on the epidemiology of West Nile virus.

  2008cites this paper
• A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.

  2008cites this paper
• Emerging viral encephalitides in dogs and cats.

  2008cites this paper
• Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).

  2007cites this paper
• West Nile virus: recent trends in diagnosis and vaccine development.

  2007cites this paper
• Experimental infections with West Nile virus

  2007cites this paper
• Complex Adenovirus-Mediated Expression of West Nile Virus C, PreM, E, and NS1 Proteins Induces both Humoral and Cellular Immune Responses

  2007cites this paper
• Adverse events following immunization: perception and evidence

  2007cites this paper
• Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development

  2007cites this paper
• Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.

  2006cites this paper
• Recent advances in flavivirus antiviral drug discovery and vaccine development.

  2006cites this paper
• A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection.

  2006cites this paper
• Feline Leukemia Virus (FeLV)- Specific IFNγ+ T-Cell Responses Are Induced in Cats Following Transdermal Vaccination With a Recombinant FeLV Vaccine

  2006cites this paper
• Pathogenesis of West Nile virus infection in dogs treated with glucocorticoids.

  2006cites this paper
• Overview of new vaccines and technologies

  2006cites this paper